Issued Patents All Time
Showing 26–34 of 34 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5939526 | Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof | Beatrice Gaugler, Peter Schrier, Nathalie Brouwenstijn, Thierry Boon-Falleur | 1999-08-17 |
| 5925729 | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof | Thierry Boon, Pierre van der Bruggen, Aline Van Pel, Etienne De Plaen, Christophe Lurquin +2 more | 1999-07-20 |
| 5858689 | Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof | Pierre van der Bruggen, Olivier DeBacker, Thierry Boon-Falleur | 1999-01-12 |
| 5695994 | Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules | Thierry Boon-Falleur, Pierre van der Bruggen, Etienne De Plaen, Christophe Lurguin, Catia Traversari +1 more | 1997-12-09 |
| 5648226 | Isolated peptides derived from tumor rejection antigens, and their use | Olivier DeBacker, Thierry Boon-Falleur | 1997-07-15 |
| 5610013 | Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors | Thierry Boon-Falleur | 1997-03-11 |
| 5512437 | Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3 | Beatrice Gaugler, Thierry Boon-Falleur, Etienne DePlaen, Francis Basseur, Bernard Lethe +1 more | 1996-04-30 |
| 5462871 | Isolated nucleic acid molecules which encode MAGE derived nonapeptides | Thierry Boon-Falleur, Pierre van der Bruggen, Etienne De Plaen, Christophe Lurquin, Catia Traversari +1 more | 1995-10-31 |
| 5342774 | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 | Thierry Boon, Pierre van der Bruggen, Aline Van Pel, Etienne De Plaen, Christophe Lurquin +2 more | 1994-08-30 |